The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Estimating the Cost of Epilepsy in Europe: A Review with Economic Modeling
Abstract
Summary: Purpose:Based on available epidemiologic, health economic, and international population statistics literature, the cost of epilepsy in Europe was estimated. Methods:Europe was defined as the 25 European Union member countries, Iceland, Norway, and Switzerland. Guidelines for epidemiological studies on epilepsy were used for a case definition. A bottom‐up prevalence‐based cost‐of‐illness approach, the societal perspective for including the cost items, and the human capital approach as valuation principle for indirect costs were used. The cost estimates were based on selected studies with common methodology and valuation principles. Results:The estimated prevalence of epilepsy in Europe in 2004 was 4.3–7.8 per 1,000. The estimated total cost of the disease in Europe was €15.5 billion in 2004, indirect cost being the single most dominant cost category (€8.6 billion). Direct health care costs were €2.8 billion, outpatient care comprising the largest part (€1.3 billion). Direct nonmedical cost was €4.2 billion. That of antiepileptic drugs was €400 million. The total cost per case was €2,000–11,500 and the estimated cost per European inhabitant was €33. Conclusions:Epilepsy is a relevant socioeconomic burden at individual, family, health services, and societal level in Europe. The greater proportion of such burden is outside the formal health care sector, antiepileptic drugs representing a smaller proportion. Lack of economic data from several European countries and other methodological limitations make this report an initial estimate of the cost of epilepsy in Europe. Prospective incidence cost‐of‐illness studies from well‐defined populations and common methodology are encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Cited by
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
SCOPE 2021: a new scorecard for osteoporosis in Europe
Kanis, J. A., Norton, N., Harvey, N. C., Jacobson, T., Johansson, H., Lorentzon, M., McCloskey, E. V., Willers, C., & Borgström, F. (2021) · Archives of Osteoporosis · doi:10.1007/s11657-020-00871-9 · Cited by 714
Infantile spasms: A U.S. consensus report
Pellock, J. M., Hrachovy, R., Shinnar, S., Baram, T. Z., Bettis, D., Dlugos, D. J., Gaillard, W. D., Gibson, P. A., Holmes, G. L., Nordli, D. R., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02657.x · Cited by 457
Wearable Electroencephalography
Casson, A., Yates, D., Smith, S., Duncan, J., & Rodriguez-Villegas, E. (2010) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2010.936545 · Cited by 404
Taylor, R. S., Sander, J. W., Taylor, R. J., & Baker, G. A. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03213.x · Cited by 393
Metadata
- Authors
- Pugliatti, M., Beghi, E., Forsgren, L., Ekman, M., & Sobocki, P.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2007-10-05
- Volume
- 48
- Issue
- 12
- Pages
- 2224-2233
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2014408954
- Cited by
- 197
- References
- 1
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimating the Cost of Epilepsy in Europe: A Review with Economic Modeling. https://app.cochat.ai/papers/10.1111/j.1528-1167.2007.01251.x
- The paper
- Pugliatti, M., Beghi, E., Forsgren, L., Ekman, M., & Sobocki, P. (2007). Estimating the Cost of Epilepsy in Europe: A Review with Economic Modeling. Epilepsia. https://doi.org/10.1111/j.1528-1167.2007.01251.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.